ZA85910B - A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form - Google Patents
A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-formInfo
- Publication number
- ZA85910B ZA85910B ZA85910A ZA85910A ZA85910B ZA 85910 B ZA85910 B ZA 85910B ZA 85910 A ZA85910 A ZA 85910A ZA 85910 A ZA85910 A ZA 85910A ZA 85910 B ZA85910 B ZA 85910B
- Authority
- ZA
- South Africa
- Prior art keywords
- crystalline
- novel
- stable
- preparation
- prazosin hydrochloride
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI842544A FI79107C (fi) | 1984-06-25 | 1984-06-25 | Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA85910B true ZA85910B (en) | 1985-09-25 |
Family
ID=8519293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA85910A ZA85910B (en) | 1984-06-25 | 1985-02-06 | A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US4739055A (de) |
| JP (1) | JPS6115881A (de) |
| AT (1) | AT389117B (de) |
| AU (1) | AU566814B2 (de) |
| BE (1) | BE900925A (de) |
| CH (1) | CH661045A5 (de) |
| DE (1) | DE3429415A1 (de) |
| FI (1) | FI79107C (de) |
| FR (1) | FR2567124B1 (de) |
| GB (1) | GB2160861B (de) |
| IL (1) | IL73267A (de) |
| IT (1) | IT1224142B (de) |
| LU (1) | LU85616A1 (de) |
| NL (1) | NL8403250A (de) |
| NZ (1) | NZ209962A (de) |
| PT (1) | PT79411B (de) |
| ZA (1) | ZA85910B (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0237608B1 (de) * | 1986-03-21 | 1992-01-29 | HEUMANN PHARMA GMBH & CO | Kristalline, wasserfreie Sigma -Form von 2-[4-(2-Furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxychinazolinhydrochlorid und Verfahren zu ihrer Herstellung |
| JP2756846B2 (ja) * | 1989-12-28 | 1998-05-25 | 住化ファインケム株式会社 | 無水のε型結晶体２―〔４―（２―フロイル）ピペラジン―１―イル〕―４―アミノ―６，７―ジメトキシキナゾリン塩酸塩及びその製造方法 |
| JPH07206857A (ja) * | 1993-12-28 | 1995-08-08 | Synthelabo Sa | アルフゾシン塩酸塩の二水和物 |
| IL157471A0 (en) * | 2001-02-24 | 2004-03-28 | Boehringer Ingelheim Pharma | Xanthine derivatives, production and use thereof as a medicament |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| US7501426B2 (en) * | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
| DE102005035891A1 (de) * | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| EP1852108A1 (de) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | Zusammensetzungen von DPP-IV-Inhibitoren |
| CA2873524C (en) | 2006-05-04 | 2018-02-20 | Boehringer Ingelheim International Gmbh | A polymeric form of 1-((4-methyl-quinazolin-2-yl)methyl)-3-7-(2-butyn-1-yl)-8-(3-(r)-aminopiperidin-1-yl)xanthine |
| PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
| KR101610005B1 (ko) * | 2007-08-17 | 2016-04-08 | 베링거 인겔하임 인터내셔날 게엠베하 | Ｆａｂ 관련 질환의 치료에 사용하기 위한 푸린 유도체 |
| AR071175A1 (es) * | 2008-04-03 | 2010-06-02 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante |
| PE20100156A1 (es) * | 2008-06-03 | 2010-02-23 | Boehringer Ingelheim Int | Tratamiento de nafld |
| KR20190016601A (ko) | 2008-08-06 | 2019-02-18 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| KR101791403B1 (ko) * | 2008-08-15 | 2017-10-30 | 베링거 인겔하임 인터내셔날 게엠베하 | Ｆａｂ-관련 질환의 치료에 사용하기 위한 퓨린 유도체 |
| WO2010029089A2 (en) | 2008-09-10 | 2010-03-18 | Boehringer Ingelheim International Gmbh | Combination therapy for the treatment of diabetes and related conditions |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| CN107011345A (zh) | 2008-12-23 | 2017-08-04 | 勃林格殷格翰国际有限公司 | 有机化合物的盐形式 |
| AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
| JP2013512229A (ja) | 2009-11-27 | 2013-04-11 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 遺伝子型が同定された糖尿病患者のリナグリプチン等のｄｄｐ−ｉｖ阻害薬による治療 |
| ES2935300T3 (es) | 2010-05-05 | 2023-03-03 | Boehringer Ingelheim Int | Combiterapia |
| CA2803504C (en) | 2010-06-24 | 2022-08-30 | Boehringer Ingelheim International Gmbh | A combination for diabetes therapy comprising linagliptin and a long-acting insulin |
| AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
| JP5876150B2 (ja) | 2011-07-15 | 2016-03-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 置換キナゾリン、これらの調製及び医薬組成物中のこれらの使用 |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| EP3685839A1 (de) | 2012-05-14 | 2020-07-29 | Boehringer Ingelheim International GmbH | Linagliptin zur verwendung in der behandlung von albuminuria und nierenbedingten erkrankungen |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| ES2950384T3 (es) | 2014-02-28 | 2023-10-09 | Boehringer Ingelheim Int | Uso médico de un inhibidor de DPP-4 |
| WO2017211979A1 (en) | 2016-06-10 | 2017-12-14 | Boehringer Ingelheim International Gmbh | Combinations of linagliptin and metformin |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2969375A (en) * | 1961-01-24 | Certification of correction | ||
| DE156532C (de) * | ||||
| BE427505A (de) * | 1937-05-25 | |||
| GB1156973A (en) * | 1965-07-06 | 1969-07-02 | Quinazoline Derivatives | |
| US3433788A (en) * | 1966-04-27 | 1969-03-18 | Union Carbide Corp | Process for recovery of amines from aqueous solutions by solvent treatment and distillation |
| US3421983A (en) * | 1967-03-07 | 1969-01-14 | Lummus Co | Azeotropic distillation of aqueous toluene diamine |
| US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
| US3743672A (en) * | 1970-05-27 | 1973-07-03 | Halcon International Inc | Separation of water in alkylene glycol mono and diester purification by azeotropic distillation |
| GB1308718A (en) * | 1970-07-01 | 1973-03-07 | Sir Soc Italiana Resine Spa | Method of separating vinyl acetate from liquid mixtures |
| IT956765B (it) * | 1972-06-22 | 1973-10-10 | Montedison Spa | Procedimento per la purificazione di 1 3 diossolano |
| US3935213A (en) * | 1973-12-05 | 1976-01-27 | Pfizer Inc. | Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives |
| US4026894A (en) * | 1975-10-14 | 1977-05-31 | Abbott Laboratories | Antihypertensive agents |
| US4001237A (en) * | 1976-02-18 | 1977-01-04 | Bristol-Myers Company | Oxazole, isoxazole, thiazole and isothiazole amides |
| US4092315A (en) * | 1976-03-01 | 1978-05-30 | Pfizer Inc. | Novel crystalline forms of prazosin hydrochloride |
| FI67699C (fi) * | 1979-01-31 | 1985-05-10 | Orion Yhtymae Oy | Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan |
| FI64367C (fi) * | 1980-02-26 | 1986-08-05 | Orion Yhtymae Oy | Foerfarande foer framstaellning av alfa-form av prazosinhydroklorid |
-
1984
- 1984-06-25 FI FI842544A patent/FI79107C/fi not_active IP Right Cessation
- 1984-08-09 DE DE19843429415 patent/DE3429415A1/de active Granted
- 1984-10-03 GB GB08424999A patent/GB2160861B/en not_active Expired
- 1984-10-15 US US06/660,871 patent/US4739055A/en not_active Expired - Lifetime
- 1984-10-19 AU AU34510/84A patent/AU566814B2/en not_active Ceased
- 1984-10-19 IL IL73267A patent/IL73267A/xx not_active IP Right Cessation
- 1984-10-23 NZ NZ209962A patent/NZ209962A/en unknown
- 1984-10-24 IT IT23292/84A patent/IT1224142B/it active
- 1984-10-25 NL NL8403250A patent/NL8403250A/nl not_active Application Discontinuation
- 1984-10-26 CH CH5142/84A patent/CH661045A5/de not_active IP Right Cessation
- 1984-10-26 PT PT79411A patent/PT79411B/pt not_active IP Right Cessation
- 1984-10-26 FR FR8416401A patent/FR2567124B1/fr not_active Expired - Lifetime
- 1984-10-29 JP JP59227640A patent/JPS6115881A/ja active Granted
- 1984-10-29 BE BE0/213911A patent/BE900925A/fr not_active IP Right Cessation
- 1984-10-29 LU LU85616A patent/LU85616A1/fr unknown
- 1984-10-30 AT AT0344184A patent/AT389117B/de not_active IP Right Cessation
-
1985
- 1985-02-06 ZA ZA85910A patent/ZA85910B/xx unknown
-
1988
- 1988-02-08 US US07/153,780 patent/US4873330A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FI842544A0 (fi) | 1984-06-25 |
| US4873330A (en) | 1989-10-10 |
| JPS6115881A (ja) | 1986-01-23 |
| FI79107C (fi) | 1989-11-10 |
| DE3429415C2 (de) | 1990-05-03 |
| DE3429415A1 (de) | 1986-01-02 |
| JPH0481993B2 (de) | 1992-12-25 |
| GB2160861B (en) | 1987-11-18 |
| PT79411B (en) | 1986-09-15 |
| FI79107B (fi) | 1989-07-31 |
| BE900925A (fr) | 1985-02-15 |
| IL73267A0 (en) | 1985-01-31 |
| ATA344184A (de) | 1989-03-15 |
| CH661045A5 (de) | 1987-06-30 |
| AT389117B (de) | 1989-10-25 |
| GB2160861A (en) | 1986-01-02 |
| IT1224142B (it) | 1990-09-26 |
| LU85616A1 (fr) | 1985-06-04 |
| IT8423292A0 (it) | 1984-10-24 |
| FR2567124B1 (fr) | 1990-09-21 |
| GB8424999D0 (en) | 1984-11-07 |
| FR2567124A1 (fr) | 1986-01-10 |
| AU3451084A (en) | 1986-01-02 |
| NL8403250A (nl) | 1986-01-16 |
| FI842544A (fi) | 1985-12-26 |
| US4739055A (en) | 1988-04-19 |
| PT79411A (en) | 1984-11-01 |
| AU566814B2 (en) | 1987-10-29 |
| IL73267A (en) | 1988-06-30 |
| NZ209962A (en) | 1987-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA85910B (en) | A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form | |
| HUT38361A (en) | Process for preparing new crystalline modifications | |
| HUT44257A (en) | Process for preparing crystalline cefalosporinhydrate | |
| YU191188A (en) | Process for preparing new ammonia compounds | |
| DE3560511D1 (en) | Pleuromutilin derivatives, process for their preparation and their use | |
| ZA862929B (en) | Process for preparing(z)-1-phenyl-1-diethylaminocarbonyl-2-aminomethyl-cyclopropane hydrochloride | |
| YU156985A (en) | Process for producing ammonia | |
| PL256373A1 (en) | Process for preparing silibinin,free of isosilibin | |
| YU228688A (en) | Process for preparing new ammonia compounds | |
| GB2167066B (en) | Process for producing urea | |
| CS690485A2 (en) | Process for preparing aminoalcohols | |
| PH23601A (en) | Process for preparing urea | |
| PT81510A (en) | Process for preparing v1-vasopressin antagonists | |
| DE3665875D1 (en) | Crystalline polyester-imides, process for production thereof, and use thereof | |
| PT85372A (en) | Bisucaderin a process for producing this compound and its use as a medicament | |
| YU45030B (en) | Process for preparing crystalline cimetidine | |
| IL84403A (en) | Process for the preparation of a nitrobenzoylalkane-sulfonamide | |
| HUT36800A (en) | Process for preparing carbamidic acid derivatives | |
| HUT44564A (en) | Novel process for preparing piroxicam-propharmakon | |
| HUT42050A (en) | Process for preparing 2-choloro-propionic acid | |
| DE3564274D1 (en) | Novel ethyl benzylphosphinate derivatives, process for production thereof, and their use as calcium antagonist | |
| YU5488A (en) | Process for producing herbicidal pyridinsulphonyl ureas | |
| EP0253360A3 (en) | Process for preparing nitriles | |
| EP0265931A3 (en) | Process for the preparation of alkylaniline using a friedel-crafts-catalysator | |
| YU44938B (en) | Process for preparing crystalline cimetidine |